Raymond James & Associates’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $64.1M | Buy |
572,808
+36,365
| +7% | +$3.64M | 0.04% | 377 |
|
|
2024
Q2 | $52.6M | Buy |
536,443
+143,866
| +37% | +$14.3M | 0.03% | 405 |
|
|
2024
Q1 | $39.3M | Sell |
392,577
-18,456
| -4% | -$1.62M | 0.03% | 485 |
|
|
2023
Q4 | $36.9M | Sell |
411,033
-1,783
| -0.4% | -$142K | 0.03% | 492 |
|
|
2023
Q3 | $31.7M | Buy |
412,816
+7,173
| +2% | +$595K | 0.03% | 508 |
|
|
2023
Q2 | $34M | Sell |
405,643
-38
| -0% | -$3.09K | 0.03% | 484 |
|
|
2023
Q1 | $34.2M | Buy |
405,681
+148,408
| +58% | +$12.7M | 0.03% | 471 |
|
|
2022
Q4 | $21M | Sell |
257,273
-169
| -0.1% | -$13.6K | 0.02% | 643 |
|
|
2022
Q3 | $18.3M | Sell |
257,442
-180,536
| -41% | -$16.2M | 0.02% | 643 |
|
|
2022
Q2 | $39.3M | Sell |
437,978
-43,628
| -9% | -$4.52M | 0.04% | 378 |
|
|
2022
Q1 | $54M | Sell |
481,606
-1,253
| -0.3% | -$147K | 0.05% | 337 |
|
|
2021
Q4 | $58.4M | Buy |
482,859
+12,182
| +3% | +$1.35M | 0.05% | 336 |
|
|
2021
Q3 | $47.4M | Buy |
470,677
+82,710
| +21% | +$9.13M | 0.04% | 368 |
|
|
2021
Q2 | $45.3M | Buy |
387,967
+95,036
| +32% | +$11.4M | 0.04% | 378 |
|
|
2021
Q1 | $32.3M | Buy |
292,931
+250,180
| +585% | +$27.2M | 0.03% | 458 |
|
|
2020
Q4 | $4.29M | Buy |
42,751
+9,595
| +29% | +$890K | ﹤0.01% | 1423 |
|
|
2020
Q3 | $2.59M | Sell |
33,156
-15,520
| -32% | -$1.17M | ﹤0.01% | 1599 |
|
|
2020
Q2 | $3.39M | Buy |
48,676
+22,144
| +83% | +$1.4M | ﹤0.01% | 1423 |
|
|
2020
Q1 | $1.24M | Sell |
26,532
-45,105
| -63% | -$2.9M | ﹤0.01% | 1848 |
|
|
2019
Q4 | $5.68M | Buy |
71,637
+13,424
| +23% | +$1.03M | 0.01% | 1177 |
|
|
2019
Q3 | $4.3M | Sell |
58,213
-559
| -1% | -$40.1K | 0.01% | 1317 |
|
|
2019
Q2 | $4.57M | Buy |
58,772
+2,695
| +5% | +$205K | 0.01% | 1261 |
|
|
2019
Q1 | $4.25M | Sell |
56,077
-7,066
| -11% | -$562K | 0.01% | 1273 |
|
|
2018
Q4 | $4.62M | Sell |
63,143
-34,119
| -35% | -$2.72M | 0.01% | 1151 |
|
|
2018
Q3 | $9.31M | Sell |
97,262
-14,059
| -13% | -$1.39M | 0.01% | 870 |
|
|
2018
Q2 | $11.1M | Sell |
111,321
-3,796
| -3% | -$401K | 0.02% | 755 |
|
|
2018
Q1 | $12.2M | Buy |
115,117
+15,876
| +16% | +$1.61M | 0.02% | 679 |
|
|
2017
Q4 | $9.2M | Buy |
99,241
+116
| +0.1% | +$10.5K | 0.02% | 805 |
|
|
2017
Q3 | $8.97M | Buy |
99,125
+8,883
| +10% | +$756K | 0.02% | 799 |
|
|
2017
Q2 | $7.58M | Buy |
90,242
+22,971
| +34% | +$1.85M | 0.02% | 842 |
|
|
2017
Q1 | $5.43M | Buy |
67,271
+7,307
| +12% | +$575K | 0.01% | 984 |
|
|
2016
Q4 | $4.51M | Buy |
59,964
+6,402
| +12% | +$462K | 0.01% | 1048 |
|
|
2016
Q3 | $3.63M | Buy |
53,562
+22,296
| +71% | +$1.5M | 0.01% | 1110 |
|
|
2016
Q2 | $2.12M | Buy |
31,266
+7,728
| +33% | +$568K | 0.01% | 1296 |
|
|
2016
Q1 | $1.7M | Buy |
23,538
+2,181
| +10% | +$143K | 0.01% | 1367 |
|
|
2015
Q4 | $1.44M | Sell |
21,357
-2,077
| -9% | -$145K | 0.01% | 1436 |
|
|
2015
Q3 | $1.52M | Sell |
23,434
-14,180
| -38% | -$1.05M | 0.01% | 1366 |
|
|
2015
Q2 | $3.08M | Buy |
37,614
+245
| +0.7% | +$18.9K | 0.01% | 1077 |
|
|
2015
Q1 | $2.59M | Sell |
37,369
-519
| -1% | -$37.5K | 0.01% | 1096 |
|
|
2014
Q4 | $2.87M | Sell |
37,888
-11,261
| -23% | -$890K | 0.01% | 957 |
|
|
2014
Q3 | $3.98M | Buy |
49,149
+12,810
| +35% | +$1.07M | 0.02% | 740 |
|
|
2014
Q2 | $3.17M | Buy |
36,339
+9,498
| +35% | +$825K | 0.02% | 851 |
|
|
2014
Q1 | $2.31M | Buy |
26,841
+2,045
| +8% | +$168K | 0.02% | 948 |
|
|
2013
Q4 | $2M | Buy |
24,796
+2,016
| +9% | +$157K | 0.02% | 965 |
|
|
2013
Q3 | $1.77M | Buy |
22,780
+10,604
| +87% | +$817K | 0.02% | 942 |
|
|
2013
Q2 | $852K | Buy |
+12,176
| New | +$849K | 0.01% | 1245 |
|
Other funds holding EMN
Raymond James & Associates's EMN Position: Q3 2024 in Review
Raymond James & Associates increased its Eastman Chemical (EMN) stake by 6.8% in Q3 2024, buying an estimated $3.64M and bringing the position to 572,808 shares worth $64.1M. The position accounts for 0.04% of the portfolio, ranked #377.
Raymond James & Associates first reported a position in EMN in Q2 2013 and has held it in 46 quarters since. 783 funds tracked by Wall St. Rank hold EMN as of Q3 2024.
- Raymond James & Associates held 572,808 shares of Eastman Chemical worth $64.1M as of Q3 2024.
- Raymond James & Associates bought 36,365 Eastman Chemical shares in Q3 2024, an estimated $3.64M.
- Eastman Chemical made up 0.04% of Raymond James & Associates's portfolio in Q3 2024, its #377 holding.
- Raymond James & Associates first reported a position in Eastman Chemical in Q2 2013 and has held it in 46 quarters since.
- 783 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.